Beam Therapeutics Inc. (BEAM) dividend history
BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/304% below fair value
$22.83−1.20 (-4.99%)
Close on Nov 13, 2026Market cap $2.36BP/E –Yield –
Dividends
Beam Therapeutics has not reported a dividend
No dividend per share appears in Beam Therapeutics's annual filings since fiscal 2018.
See a number that looks wrong?